Glycation and Diabetes Complications, Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Australia.
School of Medicine, University of Queensland, St Lucia, Australia.
Sci Rep. 2019 Sep 20;9(1):13664. doi: 10.1038/s41598-019-50221-0.
The accumulation of advanced glycation end products (AGEs) have been implicated in the development and progression of diabetic kidney disease (DKD). There has been interest in investigating the potential of AGE clearance receptors, such as oligosaccharyltransferase-48 kDa subunit (OST48) to prevent the detrimental effects of excess AGE accumulation seen in the diabetic kidney. Here the objective of the study was to increase the expression of OST48 to examine if this slowed the development of DKD by facilitating the clearance of AGEs. Groups of 8-week-old heterozygous knock-in male mice (n = 9-12/group) over-expressing the gene encoding for OST48, dolichyl-diphosphooligosaccharide-protein glycosyltransferase (DDOST+/-) and litter mate controls were randomised to either (i) no diabetes or (ii) diabetes induced via multiple low-dose streptozotocin and followed for 24 weeks. By the study end, global over expression of OST48 increased glomerular OST48. This facilitated greater renal excretion of AGEs but did not affect circulating or renal AGE concentrations. Diabetes resulted in kidney damage including lower glomerular filtration rate, albuminuria, glomerulosclerosis and tubulointerstitial fibrosis. In diabetic mice, tubulointerstitial fibrosis was further exacerbated by global increases in OST48. There was significantly insulin effectiveness, increased acute insulin secretion, fasting insulin concentrations and AUC observed during glucose tolerance testing in diabetic mice with global elevations in OST48 when compared to diabetic wild-type littermates. Overall, this study suggested that despite facilitating urinary-renal AGE clearance, there were no benefits observed on kidney functional and structural parameters in diabetes afforded by globally increasing OST48 expression. However, the improvements in insulin secretion seen in diabetic mice with global over-expression of OST48 and their dissociation from effects on kidney function warrant future investigation.
晚期糖基化终产物 (AGEs) 的积累与糖尿病肾病 (DKD) 的发生和进展有关。人们对探索 AGE 清除受体的潜力产生了兴趣,例如寡糖基转移酶-48kDa 亚基 (OST48),以防止糖尿病肾脏中过量 AGE 积累产生的有害影响。本研究的目的是增加 OST48 的表达,以观察通过促进 AGE 清除是否会减缓 DKD 的发展。将表达编码 OST48 的基因的杂合敲入雄性小鼠(n = 9-12/组)分为两组,一组过表达 OST48(DOST+/-),另一组为同窝对照,随机分为(i)无糖尿病或(ii)通过多次小剂量链脲佐菌素诱导的糖尿病,并随访 24 周。研究结束时,肾小球 OST48 的全局过表达增加。这促进了更多的肾脏 AGE 排泄,但不影响循环或肾脏 AGE 浓度。糖尿病导致肾脏损伤,包括肾小球滤过率降低、蛋白尿、肾小球硬化和肾小管间质纤维化。在糖尿病小鼠中,全局增加 OST48 进一步加剧了肾小管间质纤维化。与糖尿病野生型同窝对照相比,在糖尿病小鼠中,整体增加 OST48 导致葡萄糖耐量试验期间观察到胰岛素功效、急性胰岛素分泌、空腹胰岛素浓度和 AUC 显著增加。总体而言,这项研究表明,尽管促进了尿肾 AGE 清除,但通过全局增加 OST48 表达,在糖尿病中观察到对肾脏功能和结构参数没有益处。然而,在糖尿病小鼠中观察到的 OST48 过表达对胰岛素分泌的改善及其与肾脏功能的分离值得进一步研究。